L-asparaginase as a chemotherapeutic agent represented a milestone in the field of medicine due to the ratio of acute lymphoblastic leukemia children patients who achieve complete remission after treatment incorporating ASNase (93%) and due to its selectivity against the tumor cells. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.